Reunion Neuroscience Inc. – NASDAQ:REUN
Reunion Neuroscience stock price monthly change
Reunion Neuroscience stock price quarterly change
Reunion Neuroscience key metrics
Market Cap | 13.12M |
Enterprise value | N/A |
P/E | -0.15 |
EV/Sales | -10.78 |
EV/EBITDA | 0.37 |
Price/Sales | 5.70 |
Price/Book | 0.36 |
PEG ratio | N/A |
EPS | -4.21 |
Revenue | N/A |
EBITDA | -46.57M |
Income | -48.76M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -3257.98% |
Oper. margin | -1954.86% |
Gross margin | -56.1% |
EBIT margin | -1954.86% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeReunion Neuroscience stock price history
Reunion Neuroscience stock forecast
Reunion Neuroscience financial statements
| Sep 2021 | 907.81K | -13.01M | -1434.13% |
|---|---|---|---|
| Dec 2021 | 1.36M | -14.97M | -1100.17% |
| Mar 2022 | 1.72M | -14.54M | -843.49% |
| Mar 2023 | 0 | -6.22M |
| 2022-11-14 | -0.42 | -0.92 |
|---|---|---|
| 2023-02-14 | -0.33 | -0.43 |
| 2023-06-28 | -0.48 | -0.41 |
| 2023-09-27 | -0.07 | 1 |
| Jun 2022 | 88067831 | 34.73M | 39.44% |
|---|---|---|---|
| Sep 2022 | 43707107 | 5.46M | 12.5% |
| Dec 2022 | 36604394 | 9.88M | 27.02% |
| Mar 2023 | 29740305 | 8.44M | 28.4% |
| Sep 2021 | -11.76M | 7.41M | -358.76K |
|---|---|---|---|
| Dec 2021 | -11.18M | 7.56M | -462.39K |
| Mar 2022 | -10.41M | 54.96M | 517.04K |
| Mar 2023 | -4.42M | -362.3K | 67.66K |
Reunion Neuroscience alternative data
| Aug 2023 | 16 |
|---|---|
| Sep 2023 | 16 |
| Oct 2023 | 16 |
| Nov 2023 | 16 |
| Dec 2023 | 16 |
| Jan 2024 | 16 |
| Feb 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
Reunion Neuroscience other data
| Quarter | Transcript |
|---|---|
| Q3 2023 14 Feb 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 15 Nov 2022 | Q2 2023 Earnings Call Transcript |
| Q1 2023 16 Aug 2022 | Q1 2023 Earnings Call Transcript |
| Q4 2022 30 Jun 2022 | Q4 2022 Earnings Call Transcript |
-
When is Reunion Neuroscience's next earnings date?
Unfortunately, Reunion Neuroscience's (REUN) next earnings date is currently unknown.
-
Does Reunion Neuroscience pay dividends?
No, Reunion Neuroscience does not pay dividends.
-
How much money does Reunion Neuroscience make?
Reunion Neuroscience has a market capitalization of 13.12M. Reunion Neuroscience made a loss 66.22M US dollars in net income (profit) last year or $1 on an earnings per share basis.
-
What is Reunion Neuroscience's stock symbol?
Reunion Neuroscience Inc. is traded on the NASDAQ under the ticker symbol "REUN".
-
What is Reunion Neuroscience's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Reunion Neuroscience?
Shares of Reunion Neuroscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Reunion Neuroscience have?
As Jul 2024, Reunion Neuroscience employs 16 workers.
-
When Reunion Neuroscience went public?
Reunion Neuroscience Inc. is publicly traded company for more then 4 years since IPO on 7 Oct 2020.
-
What is Reunion Neuroscience's official website?
The official website for Reunion Neuroscience is fieldtriphealth.com.
-
Where are Reunion Neuroscience's headquarters?
Reunion Neuroscience is headquartered at 30 Duncan Street, Toronto, ON.
-
How can i contact Reunion Neuroscience?
Reunion Neuroscience's mailing address is 30 Duncan Street, Toronto, ON.
Reunion Neuroscience company profile:
Reunion Neuroscience Inc.
fieldtriphealth.comNASDAQ
16
Biotechnology
Healthcare
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Toronto, ON M5V 2C3
CIK: 0001865482
:
:
